ANDAOPHTHALMICSOLUTION/DROPS
Approved
Jun 1983
Lifecycle
Post-LOE
Competitive Pressure
30/100
Data completeness
2/8 — Basic
KAINAIR (proparacaine hydrochloride) by Alcon is clinical pharmacology proparacaine hydrochloride ophthalmic solution is a rapidly-acting topical anesthetic, with induced anesthesia lasting approximately 10-20 minutes. First approved in 1983.
Drug data last refreshed 18h ago
Mechanism of Action
CLINICAL PHARMACOLOGY Proparacaine hydrochloride ophthalmic solution is a rapidly-acting topical anesthetic, with induced anesthesia lasting approximately 10-20 minutes.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Company
Alcon
FORT WORTH, TX
Worked on KAINAIR at Alcon? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.